Article Details
Retrieved on: 2021-04-25 13:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The three-day meeting on drugs from Merck, Roche and Bristol-Myers ... finally pull the breast cancer approval from Roche's blockbuster drug Avastin.
Article found on: www.startribune.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here